Thursday 19 February 2009

Should Randomistas Rule?

After a brief lull, the debate over randomistas seems to have revived itself. Martin Ravallion’s interesting short article, 'Should the Randomistas Rule?', is a sharp indictment of the tendency to allow the method to overcome the questions we need to ask of development interventions. I highly recommend the article for a thorough read, and shall leave you with some highlights: (1) Randomizing the selection of projects and locations for randomized control trials (RCT) is unlikely; (2) variations in ‘take-up’ in treatment populations a serious problem and challenge claims of internal validity; (3) spill-over effects and ‘corruption’ of control populations is also a serious challenge to the robustness of the study; and (4) the problems with external validity, a criticism that has been done to death when arguing against RCTs

However, the point I found most striking is probably one of the most obvious ones (that my dumb brain probably knew but never articulated): An intervention tested using an RCT ‘mixes low-impact people with high-impact people’; and in complete contrast, an actual intervention will tend to have higher representation from the high impact type of people because it will be non-random and scaled up. This then completely alters the nature of the intervention itself and its potential for change through the positive externalities it creates.

2 comments:

Selvan Kumar said...

I'm always surprised that this debate is still viewed as current even though the arguments are old. James Heckman already said basically everything worth saying about the usefulness and limitations of randomized evaluations about 15 years ago - see "Randomization and Social Policy Evaluation" or "Assessing the Case for Social Experiments."

I found Deaton's recent argument that the focus of RCTs should shift from evaluation of specific programs towards the use of experiments to test theoretical mechanisms more interesting.

Suvojit said...

Well, it makes sense that the debate is relevant at a time when RCTs are finally gaining currency worldwide and are now beginning to actively compete for donor money and policy makers' attention. Obviously, popularity brings more scrutiny